Revenue Recognition Segment revenue by major payor (Tables)

6 Months Ended

Jun. 30, 2022

Disaggregation of Revenue [Table Text Block]

The following tables summarize the Company's segment revenues by primary payor source:


	Three months ended June 30, 2022						Three months ended June 30, 2021
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,529,534	$		$	1,529,534	$	1,562,164	$		$	1,562,164
Medicaid and Managed Medicaid	186,873				186,873		194,641				194,641
Other government	86,079		116,653		202,732		82,317		118,464		200,781
Commercial	854,662		55,708		910,370		830,801		50,817		881,618
Other revenues:
Medicare and Medicare Advantage			93,262		93,262				80,211		80,211
Medicaid and Managed Medicaid			232		232				305		305
Commercial			8,207		8,207				1,189		1,189
Other(1)	6,092		8,844		14,936		6,415		10,503		16,918
Eliminations of intersegment revenues	(19,389)				(19,389)		(21,317)		—		(21,317)
Total	$	2,643,851	$	282,906	$	2,926,757	$	2,655,021	$	261,489	$	2,916,510

(1)Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.


	Six months ended June 30, 2022						Six months ended June 30, 2021
	U.S. dialysis		Other - Ancillary services		Consolidated		U.S. dialysis		Other - Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	2,993,621	$		$	2,993,621	$	3,042,461	$		$	3,042,461
Medicaid and Managed Medicaid	376,528				376,528		381,884				381,884
Other government	166,879		233,548		400,427		162,501		225,293		387,794
Commercial	1,689,240		108,132		1,797,372		1,666,280		102,315		1,768,595
Other revenues:
Medicare and Medicare Advantage			176,859		176,859				165,807		165,807
Medicaid and Managed Medicaid			769		769				605		605
Commercial			9,546		9,546				7,223		7,223
Other(1)	12,068		18,680		30,748		13,091		21,665		34,756
Eliminations of intersegment revenues	(41,558)				(41,558)		(48,320)		(4,294)		(52,614)
Total	$	5,196,778	$	547,534	$	5,744,312	$	5,217,897	$	518,614	$	5,736,511

(1) Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.